| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Across the last three months, Ocular Therapeutix, Inc.'s insiders have reduced their positions by a net 63,819 shares worth roughly $568K. In the past 30 days, 0 insiders bought and 3 sold. The bias lately has been to the sell side.
Not all activity pointed one way: 3 insiders sold in the same window, though all of them still hold shares. Classified under Biotechnology (Health Care sector), OCUL's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 416.0K | - | - | |
| COO | 366.5K | $3.75M | - | |
| Other | 326.9K | $3.52M | - | |
| Other | 307.5K | $2.17M | -10,869 | |
| Other | 300.1K | $2.48M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 15, 2015 | Versant Venture Capital Iii, L.P. | 10% Owner | Sell | 320,000 | $22.00 | $7,040,000.00 | -96.1% | |
| Jun 15, 2015 | Warden Charles M | Director, 10% Owner | Sell | 320,000 | $22.00 | $7,040,000.00 | -96.1% | |
| Jun 10, 2015 | Svlsf Iv, LLC | 10% Owner | Sell | 1,119,000 | $22.00 | $24,618,000.00 | -94.8% | |
| Jun 10, 2015 | Versant Venture Capital Iii, L.P. | 10% Owner | Sell | 427,000 | $22.00 | $9,394,000.00 | -96.6% | |
| Jun 10, 2015 | Warden Charles M | Director, 10% Owner | Sell | 427,000 | $22.00 | $9,394,000.00 | -96.6% | |
| Feb 2, 2015 | Polaris Venture Management Co. V, L.l.c. | 10% Owner | Sell | 500,000 | $29.50 | $14,750,000.00 | -96.2% |